These effects were large in magnitude (e.g., >sixfold increase for sgPten) and included many genes that reduce tumor number (e.g., >fourfold decrease for sgLkb1), suggesting several of these tumor suppressor genes do not in fact suppress EGFR-driven tumors (Fig. 5D). The gene discussed is EGFR; the disease is neoplasm.